New guidelines regulate dual-energy x-ray absorptiometry and monitoring techniques for bone assessment, indicating updated practices.
The press release informs about the new provisions that were introduced into the latest version (2023) of the clinical recommendations of the International Society for Clinical Densitometry. The provisions relate to equipment whose use is scientifically justified from the point of view of evidence-based medicine. The use of dual-energy X-ray absorptiometry (DRA) and other technologies for bone tissue assessment is regulated by these recommendations. Changes and additions to the 2023 recommendations relate to the monitoring of measurements and the formation of standard conclusions on DХA; additional DХA programs for assessing the condition of the trabecular bone – the trabecular bone index (TBS) and hip imaging for the prognosis of atypical fractures. Changes and new provisions have been added to this document due to their increasing relevance and importance of use at the present time.
No takes yet. Share an insight, caveat, or question.
Скрипникова et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: